9-ING-41 in Patients With Advanced Cancers
A phase 2 trial of Gemcitabine, Doxorubicin, Pegylated liposomal doxorubicin in hodgkin lymphoma and non-hodgkin lymphoma, run by Actuate Therapeutics Inc., active and no longer recruiting.
Overview
9-ING-41 in Patients With Advanced Cancers is a phase 2 interventional study registered as NCT03678883 by Actuate Therapeutics Inc., with 350 participants planned, started 2019-01-04 and due to reach its primary completion in 2026-06. Interventions recorded: 9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin., Lomustine, Carboplatin.. Conditions listed: Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialMirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
Shares Pegylated liposomal doxorubicin, Doxorubicin, Gemcitabine, Carboplatin.
- TrialA Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Shares Pegylated liposomal doxorubicin, Doxorubicin, Gemcitabine.
- TrialStudy to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Shares Pegylated liposomal doxorubicin, Gemcitabine, Paclitaxel / nab-paclitaxel.
- TrialAn Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Can
Shares Pegylated liposomal doxorubicin, Gemcitabine, Paclitaxel / nab-paclitaxel.
- TrialA Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Shares Pegylated liposomal doxorubicin, Paclitaxel / nab-paclitaxel.
- TrialStudy to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- TrialA Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Carboplatin.